Navigation Links
Care Investment Trust Names Walter J. Owens to Board of Directors
Date:4/17/2008

NEW YORK, April 17 /PRNewswire-FirstCall/ -- Care Investment Trust Inc. (NYSE: CRE) today announced it named Walter J. Owens, President of Corporate Finance at CIT, to Care's Board of Directors, which increases the number of members from six to seven directors.

In his capacity as President of Corporate Finance at CIT, Owens, 48, is responsible for working with CIT's Corporate Finance business unit leaders in assessing their go-to-market models, developing integrated distribution platforms that serve a broad range of product offerings and customer segments, and improving operational efficiencies. Previously, he was Executive Vice President and Chief Sales and Marketing Officer of CIT. Prior to joining CIT, he served as Chief Marketing Officer for GE Commercial Finance. Before GE, Owens served in a number of positions with Citibank and Deloitte & Touche LLP.

Kirk Gorman, Chairman of the Board of Directors, commented, "Walter brings a wealth of financial, operational and sales experience to Care's Board. We look forward to his counsel and participation in the further development of Care."

About Care Investment Trust

Care Investment Trust Inc. is a real estate investment and finance company formed principally to invest in healthcare-related commercial mortgage debt and real estate. It is externally managed and advised by CIT Healthcare LLC, a wholly-owned subsidiary of CIT Group Inc.

Safe Harbor Statement

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements (including statements regarding future financial and operating results) involve risks, uncertainties and contingencies, many of which are beyond Care Investment Trust's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," "target," and similar expressions are generally intended to identify forward-looking statements. Economic, business, funding market, competitive and/or regulatory factors, among others, affecting Care Investment Trust's businesses are examples of factors that could cause actual results to differ materially from those described in the forward-looking statements in addition to those factors specified in Care Investment Trust's Registration Statement on Form S-11 relating to its initial public offering and its Annual Report of Form 10-K for the period ended December 31, 2007. Care Investment Trust is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

For more information on Care Investment Trust, please visit their website at http://www.carereit.com


'/>"/>
SOURCE Care Investment Trust Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. White Ribbon Alliance Calls for Investments to Save Womens Lives Lost in Pregnancy and Childbirth
2. SCI Real Estate Investments Joins City of Hope to Fight Cancer
3. Sunrise Senior Living Names Mark Ordan Chief Investment and Administrative Officer
4. Mindray to Attend the 11th Credit Suisse Asian Investment Conference
5. Turner Investment Partners Added to AHA Diversified Equity Fund
6. Americas Top Pediatric Medical Institutions Unite to Drive Increased Federal Investment in Pediatric Research
7. Catholic Health Initiatives Makes $10 Million Investment in Calvert Foundations Community Investment Notes
8. Increased Investment in Medicaid Needed to Protect Houston Areas Most Vulnerable Seniors, Disabled
9. Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results
10. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
11. Childrens Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
Breaking Medicine Technology: